These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8751102)

  • 1. Long-term treatment of blepharospasm with botulinum toxin type A.
    Nüssgens Z; Roggenkämper P
    Ger J Ophthalmol; 1995 Nov; 4(6):363-7. PubMed ID: 8751102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of botulinum toxin type A for the treatment of facial spasm.
    Serrano LA
    Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the treatment of paralytic strabismus and essential blepharospasm.
    Thomas R; Mathai A; Rajeev B; Sen S; Jacob P
    Indian J Ophthalmol; 1993 Oct; 41(3):121-4. PubMed ID: 8125543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
    Wang J; Lin S; Zhang X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
    Ziak P
    Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of blepharospasm with botulinum toxin A].
    Költringer P; Haselwander H; Reisecker F
    Wien Klin Wochenschr; 1990 Jul; 102(14):403-7. PubMed ID: 2382447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blepharospasm treatment with botulinum toxin (follow-up)].
    Roggenkämper P
    Klin Monbl Augenheilkd; 1986 Oct; 189(4):283-5. PubMed ID: 3807220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontalis suspension for essential blepharospasm unresponsive to botulinum toxin therapy. First results.
    Roggenkämper P; Nüssgens Z
    Ger J Ophthalmol; 1993 Nov; 2(6):426-8. PubMed ID: 8312829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report.
    Spiera H; Asbell PA; Simpson DM
    J Rheumatol; 1997 Sep; 24(9):1842-3. PubMed ID: 9292815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of blepharospasm with botulinum toxin].
    Pikielny RT; Micheli FE; Fernández Pardal MM; Casas Parera I; Giannaula RJ; Gatto M
    Medicina (B Aires); 1990; 50(2):129-34. PubMed ID: 2101846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for the treatment of essential blepharospasm.
    Shore JW; Leone CR; O'Connor PS; Neuhaus RW; Arnold AC
    Ophthalmic Surg; 1986 Nov; 17(11):747-53. PubMed ID: 3808585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor nerve sprouting in human orbicularis muscle after botulinum A injection.
    Holds JB; Alderson K; Fogg SG; Anderson RL
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):964-7. PubMed ID: 2335457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A five-year analysis of botulinum toxin type A injections: some unusual features.
    Balkan RJ; Poole T
    Ann Ophthalmol; 1991 Sep; 23(9):326-33. PubMed ID: 1741604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.